Faes Farma, S.A. (LON:0K9H)

Market Cap	1.27B
Revenue (ttm)	498.51M
Net Income (ttm)	91.72M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	13.87
Forward PE	15.38
Dividend	0.12 (2.78%)
Ex-Dividend Date	Jul 3, 2025

Volume	9,644
Average Volume	4,301
Open	4.568
Previous Close	4.640
Day's Range	4.555 - 4.620
52-Week Range	3.270 - 4.735
Beta	0.19
RSI	63.34
Earnings Date	Nov 3, 2025

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec...

• Industry: Pharmaceutical Preparations
• Founded: 1933
• Employees: 1,775
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0K9H

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.

Financial numbers in EUR